Development and clinical application of new polyvalent combined paediatric vaccines

Vaccine

Volumn 17, Issue 13-14, 1999, Pages 1620-1627

  André, Francis E ^a  

^a GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Combined paediatric vaccines

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS VACCINE; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; PENTACOQ; UNCLASSIFIED DRUG;

ANOREXIA; CHILD; CHILDHOOD DISEASE; CONFERENCE PAPER; DIPHTHERIA; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; FEVER; HEPATITIS B; HUMAN; IMMUNIZATION; INFANT; INFLUENZA; PAIN; PERTUSSIS; PRIORITY JOURNAL; TETANUS; VACCINATION;

CHILD; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION; VACCINES, COMBINED;

EID: 0344428142     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00426-5     Document Type: Conference Paper

References (35)

1. The World Bank. World development report 1993. Investing in health. World development indicators. New York, USA: Oxford University Press, 1993.
2. Tengs T.O., Adams M.E., Pliskin J.S.et al. Five hundred life-saving interventions and their cost-effectiveness. Risk Anal. 15:1995;369-390.
3. WHO, UNICEF. State of the World's vaccines and immunization, 1996. Geneva: World Health Organisation, 1996. WHO/GPV/9604.
4. Jenner E. An inquiry into the causes and effects of the variolae vaccinae, a disease discovered in some of the western countries of England, particularly Gloustershire, known by the name of the cow pox. London, 1798.
5. Fenner F, Henderson DA, Arita L, Jezek Z, Ladnji ID. Smallpox and its eradication. Geneva: World Health Organisation, 1988.
6. Jefferson T. Vaccination and its adverse effects: real or perceived? Br. Med. J. 317:1998;159-160.
7. National Institutes of Health. The Jordan report. Accelerated development of vaccines. Bethesda, USA, 1998.
8. Rappuoli R., Locht C., Poolman J., André F., Dougan G. New vaccines, especially new combined vaccines. Vaccine. 14:1996;691-700.
9. Coursaget P., Yvonnet B., Relyveld E.H.et al. Simultaneous administration of diphtheria/tetanus/pertussis/polio and hepatitis B vaccines in a simplified immunization programme: immune response to diphtheria toxoid, tetanus toxoid, pertussis and hepatitis B surface antigen. Infect. Immun. 51:1986;784-787.
10. Children's Vaccine Initiative. Report of the 2nd Meeting of the Consultative Group Geneva, 16-17 November 1992. CVI/CG-2/92. p. 2-3.
11. André F.E. Development of combined vaccines: manufacturers' viewpoint. Biologicals. 22:1994;317-321.
12. Papaevangelou G., Karvelis E., Alexiou D.et al. Evaluation of a combined tetravalent diphtheria, tetanus, whole-cell pertussis and hepatitis B candidate vaccine administered to healthy infants according to a three-dose vaccination schedule. Vaccine. 13:1995;175-178.
13. André FE. The way forward: combined vaccines in Hepatitis B vaccination, moving forward to the next decade. Chester, England: Adis International, 1996. p. 9-11.
14. Wim K.M., Aye M., Htay-Htay H., Safary A., Bock H. Comparison of separate and mixed administration of DTPw-HBV and HIB vaccines: immunogenicity and reactogenicity profiles. Int. J. Infect. Dis. 2(2):1997;79-84.
15. Bogaerts H., Capiau C., Hauser P.et al. Overview of the clinical development of a diphtheria-tetanus-acellular pertussis vaccine. J. Infect. Dis. 174 (Suppl 3):1996;S276-S280.
16. André F, Cholat J, Furminger I, editors. Proceedings 2nd European Conference on Vaccinology: combined vaccines for Europe, pharmaceutical, regulatory and policy-making aspects. Biologicals 1994;22(4):297-436.
17. Zepp F., Schmitt H.-J., Kaufhold A.et al. Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life: plain Haemophilus influenzae type b-PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTPa-HBV combined vaccine. Eur. J. Pediatr. 157:1997;18-24.
18. Yeh S.H., Partridge S., Marcy S.M.et al. A randomised study of the safety and immunogenicity of DTPa-HB-IPV vaccine administered as three doses or in a sequential IPV/OPV schedule at 2, 4 and 6 months of age. Pediatr. Res. 43(4 (Part 2 of 2)):1998;161A.
19. Blatter M.M., Reisinger K.S., Terwelp D.R., Delbuono F.J., Howe B.J. Immunogenicity of a combined diphtheria-tetanus-acellular pertussis (DT-tricomponent Pa)-hepatitis B (HB)-inactivated poliovirus (IPV) admixed with Haemophilus influenzae type b (HIB) vaccine in infants. Pediatr. Res. 43(4 (Part 2 of 2)):1998;141A.
20. Infanrix™ Hep B Product Monograph. Belgium: SmithKline Beecham Biologicals, 1997. p 32-3.
21. Dagan R., Igbania K., Piglansky L.et al. Safety and immonogenicity of a combined pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus and Haemophilus influenzae type b, tetanus conjugate vaccine in infants, compared with a whole cell pertussis pentavalent vaccine. Pediatr. Infect. Dis. J. 16:1997;1113-1121.
22. Kanra G., Ceylan M., Ecevit Z.et al. Primary vaccination of infants with a combined diphtheria-tetanus-acellular pertussis-hepatitis B vaccine. Pediatr. Infect. Dis. J. 14(11):1995;998-1000.
23. Usonis V., Bakasenas V., Willems P., Clemens R. Feasibility study of a combined diphtheria-tetanus-acellular pertusis-hepatitis B (DTPa-HBV) vaccine, and comparison of clinical reactions and immune response with diphtheria-tetanus-acellular pertussis (DTPa) and hepatitis B vaccines applied as mixed or injected into separate limbs. Vaccine. 15(15):1997;1680-1686.
24. Giammanco G., Moiraghi A., Zotti C.et al. Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertusis-hepatitis B vaccine administered according to two different primary vaccination schedules. Vaccine. 16(7):1998;722-726.
25. Faldella G, Alessandroni R, Magini GM et al. The preterm infant's antibody response to a combined diphtheria, tetanus, acellular pertussis and hepatitis B vaccine. Vaccine 1998; 16(17):1646-1649.
26. Eskola J., Ölander R.M., Hovi T.et al. Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine. Lancet. 348:1996;1688-1692.
27. Eskola J, Käyhty H, Willems P, Bogaerts H, Kaufhold A. 16th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID), 27-29 May 1998. Bled, Slovenia. Abstract 07.
28. Schmitt H.J., Zepp F., Müsschenborn S.et al. Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine from primary and for booster immunisations. Eur. J. Pediatr. 157:1998;208-214.
29. Eskola J, Käyhty H, Takala AK, Peltola H et al. A randomised, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. N. Engl. J. Med. 1990; 323:1381-1387.
30. Decker M, Edwards K, Bradley R, Palmer P. Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines. J. Pediatr. 1992; 2:184-189.
31. Granoff DM, Holmes SJ, Osterholm MT et al. Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines. J. Infect. Dis. 1993; 168:663-671.
32. Bégué P., Stagnara J., Vie-le-Sage F.et al. Immunogenicity and reactogenicity of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccines given concurrently with Haemophilus influenzae type b conjugate vaccine or as pentavalent vaccine. Pediatr. Infect. Dis. J. 16(8):1997;787-794.
33. Bégué P, Grimprel E, Giovannangeli MD, Abitbol V. Immunogenicity and reactogenicity of a booster dose of DTPa-IPV compared to one dose of DT-IPV administered to preadolescents aged 10-13 years. 16th Annual Meeting of the European Society for Peadiatric Infectious Diseases (ESPID), 27-29 May 1998. Bled, Slovenia. p. 52.
34. Willems P, Kaufhold A. Clinical experience with a pentavalent combination vaccine: DTPA-IPV/Hib overview. 16th Annual Meeting of the European Society for Peadiatric Infectious Diseases (ESPID), 27-29 May 1998. Bled, Slovenia. p. 49.
35. André FE, Stanbury WJ, Teuwen DE. Conventional and new generation combined vaccines. In: Kurstak E, editor. Modern vaccinology. New York, London: Plenum Medical Book Company, 1994. p. 41-54.